THC Tenet Healthcare Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Tenet Healthcare Corp. and Certain Officers and Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Tenet Healthcare Corp. (“Tenet Healthcare” or the “Company”) (NYSE:THC) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.

On October 3, 2016, Tenet Healthcare revealed that it would pay $514 million to state and federal governments to settle allegations that the Company’s hospitals in Georgia and South Carolina paid kickbacks for obstetric referrals. Under the terms of the settlement, two Tenet subsidiaries will plead guilty to one count of conspiracy to violate federal kickback laws. Following this news, Tenet stock dropped $0.91 per share, or 4.02%, to close at $21.75 on October 3, 2016. To obtain additional information about the investigation, go to:

http://zlk.9nl.com/tenet-healthcare-thc

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
05/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tenet Healthcare Corporation

Tenet Healthcare Corp: 1 director

A director at Tenet Healthcare Corp sold 2,178 shares at 197.470USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Magnificent Seven's Turn to Shine We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and the S&P 500 (SPX) is above 6200 (up from 6028-6059). Additionally, we discussed since our 10/14/25 Compass how our near-term bullish outlook remains intact as long as the SPX holds above 6550-6569, which coincided with the ...

Moody's Ratings assigns Ba3 and B2 ratings to Tenet Healthcare's propo...

Moody's Ratings (Moody's) assigned Ba3 rating to Tenet Healthcare Corporation's ("Tenet") proposed offering of senior secured first lien notes due 2032 and B2 rating to the senior unsecured notes proposed offering due 2033. Tenet intends to use the net proceeds from this offering for general corpora...

Tenet Healthcare Corporation: Update to credit analysis

Our credit view of this issuer reflects its considerable scale and its very good liquidity and favorable debt maturity profile, offset by its moderately high financial leverage.

Moody's Ratings affirms Tenet Healthcare Corporation's Ba3 CFR; revis...

Moody's Ratings (Moody's) affirmed the ratings of Tenet Healthcare Corporation ("Tenet") including the Ba3 Corporate Family Rating (CFR), Ba3-PD Probability of Default Rating (PDR), Ba3 ratings of senior secured first and second lien notes and B2 rating of senior unsecured notes. At the same time, w...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch